
Insurance firms play a critical role in the financial system, offering everything from property coverage to life insurance and specialized risk solutions. But concerns about claims severity and tightening regulations have tempered enthusiasm, limiting the industry’s gains to 1.1% over the past six months. This return lagged the S&P 500’s 16.5% climb.
While some insurers have strong balance sheets and diversified product offerings that enable them to thrive in any environment, the odds aren’t great for the ones we’re analyzing today. On that note, here are three insurance stocks we’re swiping left on.
Market Cap: $3.82 billion
Rebranded from Conseco in 2010 to signal a fresh start after navigating financial challenges, CNO Financial Group (NYSE:CNO) develops and markets health insurance, annuities, and life insurance products primarily targeting middle-income pre-retirees and retirees.
Why Do We Think Twice About CNO?
CNO Financial Group is trading at $39.40 per share, or 1.5x forward P/B. To fully understand why you should be careful with CNO, check out our full research report (it’s free).
Market Cap: $24.37 billion
Often referred to as a "mini Berkshire Hathaway" for its three-engine business model of insurance, investments, and wholly-owned businesses, Markel Group (NYSE:MKL) is a specialty insurance company that underwrites complex risks, manages investment portfolios, and owns a diverse collection of operating businesses.
Why Are We Wary of MKL?
Markel Group’s stock price of $1,926 implies a valuation ratio of 1.4x forward P/B. Dive into our free research report to see why there are better opportunities than MKL.
Market Cap: $5.64 billion
Playing a critical role in helping first-time homebuyers access the housing market, Enact Holdings (NASDAQ:ACT) provides private mortgage insurance that enables lenders to offer home loans with lower down payments while protecting against borrower defaults.
Why Is ACT Not Exciting?
At $38.22 per share, Enact Holdings trades at 1x forward P/B. Read our free research report to see why you should think twice about including ACT in your portfolio.
Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.
Take advantage of the rebound by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Aug-07 | |
| Aug-06 | |
| Aug-05 | |
| Jul-31 | |
| Jul-31 | |
| Jul-30 | |
| Jul-30 | |
| Jul-16 | |
| Jun-17 | |
| May-12 | |
| May-06 | |
| May-02 | |
| May-01 | |
| Apr-30 | |
| Apr-30 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite